BioCatalystWatch
IDYAWorkspace / IDYA / OverviewCompany library
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (IDYA)

Website

Price
Market cap
Next catalystExpected 2026IDE161 · Trial initiationCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

IDE034

B7-H3 × PTK7

PreINDP1P2P3FilingApproved
Upcoming / outlook

IDE892

PRMT5

PreINDP1P2P3FilingApproved
Upcoming / outlook

IDE161

PARG

PreINDP1P2P3FilingApproved
Upcoming / outlook

IDE849

DLL3

PreINDP1P2P3FilingApproved
Upcoming / outlook

IDE849

DLL3

PreINDP1P2FilingApproved
Upcoming / outlook

IDE849

DLL3

PreINDP1P2FilingApproved
Upcoming / outlook

IDE849

DLL3

PreINDP1P3FilingApproved
Upcoming / outlook

IDE892

PRMT5

PreINDP1P2P3FilingApproved

IDE892

PRMT5

PreINDP2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

IDE161

PARG

PreINDP1P2P3FilingApproved
Upcoming / outlook

IDE849

DLL3

PreINDP1P3FilingApproved
Upcoming / outlook

IDE849

DLL3

PreINDP1P2FilingApproved
Upcoming / outlook

IDE849

DLL3

PreINDP1P2FilingApproved
Upcoming / outlook

IDE892

PRMT5

PreINDP2P3FilingApproved
Upcoming / outlook

IDE034

B7-H3 × PTK7

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

IDE892

PRMT5

PreINDP1P2P3FilingApproved
IDE574

KAT6 × KAT7

PreINDP1P2P3FilingApproved
IDE574

KAT6 × KAT7

PreINDP1P2P3FilingApproved
IDE574

KAT6 × KAT7

PreINDP1P2P3FilingApproved
IDE574

KAT6 × KAT7

PreINDP1P2P3FilingApproved
darovasertib

PKC

PreINDP1P2P3FilingApproved
darovasertib

PKC

PreINDP1P2P3FilingApproved
IDE161

PARG

IDE161

PARG

PreINDP1P2P3FilingApproved
IDE161

PARG

IDE849

DLL3

PreINDP1P2P3FilingApproved

Partner / License out

IDE849

DLL3

PreINDP1P2P3FilingApproved
IDE849

DLL3

PreINDP1P2FilingApproved
Upcoming / outlook

POLQ helicase

PreINDP1P2P3FilingApproved

WRN helicase

PreINDP1P2P3FilingApproved

WRN helicase

PreINDP1P2P3FilingApproved

WRN helicase

PreINDP1P2P3FilingApproved

History / paused

MAT2A

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

IDYA PR & News

IDYA SEC archive